Medicinal Chemistry and Protein Degradation Summit

Dassault Systèmes BIOVIA

Dassault Systèmes, the 3DEXPERIENCE Company, is a catalyst for human progress. We provide business and people with collaborative virtual environments to imagine sustainable innovations. By creating ‘virtual experience twins’ of the real world with our 3DEXPERIENCE platform and applications, our customers push the boundaries of innovation, learning and production. 

Dassault Systèmes’ 20,000 employees are bringing value to more than 270,000 customers of all sizes, in all industries, in more than 140 countries. For more information, visit www.3ds.com

Mcule

Mcule is a leading compound sourcing partner with a large purchasable chemical space. Our partners can easily get their selected building blocks and screening compounds because our database currently contains more than 43 million purchasable compounds from more than 100 chemical suppliers.

Our new exciting digital product is the ULTIMATE project, which will open a new dimension in compound sourcing: a new, artificial chemical space of 500 million novel, diverse and synthetically feasible compounds.

https://mcule.com

Eurofins Discovery

Eurofins Discovery supports drug discovery through the combined expertise of Cerep, DiscoverX, Panlabs, Villapharma, and Selcia Drug Discovery. We offer a broad portfolio including medicinal and synthetic chemistry, in vitro pharmacology products and services, cell-based phenotypic assays, ADME-Tox, in vivo drug safety and efficacy, custom proteins, and assay development services.

https://www.eurofinsdiscoveryservices.com/

Liverpool ChiroChem

Liverpool ChiroChem is a chemical technology innovator that produces chiral small molecules for biotech/pharmaceutical R&D. As the Home of Chiral N-Heterocycles, our expert synthetic technologies provide access to a variety of novel, sp3-rich, compact, chiral building blocks, in order to reach new chemical space for hit identification. Our proprietary products are ideally suited for DNA-Encoded Library synthesis and Fragment Based Lead Discovery, which many medicinal chemists consider to be leading areas of modern-day drug discovery.

http://www.liverpoolchirochem.com/

Selvita

Selvita is a global integrated drug discovery CRO specialising in variety of drug discovery processes from in silico drug design, and synthesis of a target-focused library, SAR and ADME-driven lead optimization and toxicity prediction, followed by complex preclinical in vitro development, all tailored to the customer’s needs.

WuXi AppTec

WuXi AppTec is a leading pharmaceutical and medical device open-access capability and technology platform company. As an innovation-driven and customer-focused organisation, WuXi AppTec provides a broad and integrated portfolio of services to help our partners shorten the discovery and development time through cost-effective and efficient solutions.

https://www.wuxiapptec.com/

Schrodinger

Schrödinger is a leading provider of advanced molecular simulations and enterprise software solutions that accelerate and increase the efficiency of drug discovery and materials design. Founded in 1990, Schrödinger has  nearly 400 employees and operations across the world. For more information, please visit www.schrodinger.com.

ChemPass

ChemPass develops and utilizes software and technology for the pharmaceutical industry including a rule-based AI technology for multi-step in silico forward-synthesis that can be utilized for the design of novel synthetically feasible scaffolds and, lead analogs, or for various other general or targeted design tasks. The user friendly SynSpace software (and API) has been available for medicinal and computational chemists, while ChemPass provides lead optimization service using its automated design and ranking platform.

https://www.chempassltd.com/